A detailed history of Kenfarb & Co. transactions in Pfizer Inc stock. As of the latest transaction made, Kenfarb & Co. holds 11,700 shares of PFE stock, worth $300,105. This represents 0.36% of its overall portfolio holdings.

Number of Shares
11,700
Previous 11,700 -0.0%
Holding current value
$300,105
Previous $429,000 9.56%
% of portfolio
0.36%
Previous 0.38%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$43.76 - $53.42 $8,752 - $10,684
200 Added 1.74%
11,700 $512,000
Q4 2021

Feb 14, 2022

BUY
$41.32 - $61.25 $475,180 - $704,375
11,500 New
11,500 $679,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $144B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Kenfarb & Co. Portfolio

Follow Kenfarb & Co. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kenfarb & Co., based on Form 13F filings with the SEC.

News

Stay updated on Kenfarb & Co. with notifications on news.